 Evaluation new bladder tumor marker monoclonal antibodies bind bladder tumor-associated antigen Preliminary data antigen-positive tumors detectable amounts antigen urine antigen-negative tumors antigen normal malignant urothelial cells Further characterization antigen evaluation urinary marker antigen positive bladder cancers